Back

Acoustically activatable drug-loaded nanodroplets for mechanochemical therapy in solid tumors

Bercovici, T.; Bismuth, M.; Goldsmith, M.; Peer, D.; Ilovitsh, T.

2026-04-22 cancer biology
10.64898/2026.04.20.719550 bioRxiv
Show abstract

Stimulus-responsive nanomedicines promise spatiotemporally controlled therapy, yet most systems rely on passive delivery and lack precise, externally programmable activation while maintaining clinical compatibility. Here we engineer sub-200 nm, perfluorocarbon (PFC)-core nanodroplets (NDs) that integrate efficient core drug loading, physiological stability, and acoustically programmable activation within a single nanoscale agent. These NDs are fabricated using microfluidic nanoassembly to achieve controlled size and composition, and are designed to encapsulate fluorinated payloads directly within the liquid core. Upon exposure to a sequential dual-frequency ultrasound (US) paradigm, the NDs undergo acoustic droplet vaporization followed by low-frequency cavitation, enabling spatially confined mechanical disruption and on-demand payload release within clinically relevant acoustic limits. These properties are engineered to overcome physicochemical barriers in solid tumors, including dense extracellular matrix and restricted drug penetration. This approach achieves enhanced payload release and induces potent mechanochemical cytotoxicity in vitro. In vivo, NDs exhibit prolonged circulation and tumor accumulation, while US activation drives substantial tissue fractionation, control drug release, and increases subsequent nanoparticle uptake. When applied to a solid tumor model, this combined mechanochemical strategy improves tumor control and significantly extends survival compared to either modality alone. These acoustically activatable NDs provide a versatile system for stimulus-responsive, site-targeted drug delivery and mechanical tumor disruption, with strong potential for clinical translation. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=99 SRC="FIGDIR/small/719550v1_ufig1.gif" ALT="Figure 1"> View larger version (52K): org.highwire.dtl.DTLVardef@5d9753org.highwire.dtl.DTLVardef@7a07e1org.highwire.dtl.DTLVardef@19b69f3org.highwire.dtl.DTLVardef@48f332_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Advanced Materials
53 papers in training set
Top 0.1%
22.9%
2
ACS Nano
99 papers in training set
Top 0.1%
12.6%
3
Angewandte Chemie International Edition
81 papers in training set
Top 0.1%
10.3%
4
Advanced Science
249 papers in training set
Top 1%
9.3%
50% of probability mass above
5
Advanced Functional Materials
41 papers in training set
Top 0.3%
8.6%
6
Nature Communications
4913 papers in training set
Top 26%
6.9%
7
Journal of the American Chemical Society
199 papers in training set
Top 2%
3.7%
8
Journal of Controlled Release
39 papers in training set
Top 0.4%
2.1%
9
Science Advances
1098 papers in training set
Top 12%
2.1%
10
Nature Materials
21 papers in training set
Top 0.4%
1.9%
11
Nature Physics
39 papers in training set
Top 0.8%
1.2%
12
Nature Nanotechnology
30 papers in training set
Top 0.8%
1.2%
13
ACS Applied Materials & Interfaces
39 papers in training set
Top 0.8%
0.9%
14
Angewandte Chemie
12 papers in training set
Top 0.2%
0.9%
15
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
16
Bioactive Materials
18 papers in training set
Top 0.7%
0.8%
17
ACS Central Science
66 papers in training set
Top 2%
0.8%
18
Advanced Healthcare Materials
71 papers in training set
Top 2%
0.8%
19
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 45%
0.7%
20
Molecular Cancer
14 papers in training set
Top 1%
0.7%
21
Communications Biology
886 papers in training set
Top 28%
0.7%